We read with interest the randomized study by Habara et al. (1) comparing paclitaxel-eluting balloon (PB) (n ϭ 25) with conventional balloon (BA) (n ϭ 25) in patients suffering from sirolimuseluting stent (SES) in-stent restenosis (ISR). In these patients, PB provided a dramatic improvement in angiographic parameters at late follow-up, compared with BA. This information is timely, because ISR after drug-eluting stent (DES) implantation is becoming a growing concern due to the widespread use of DES in increasingly complex anatomic scenarios (2). This study nicely complements a pioneer randomized trial where PB were also strikingly superior to BA in patients with bare-metal ISR (3). Actually, in-segment late angiographic loss after PB (0.03 mm) was even lower than that found in the present study in SES ISR (0.18 mm) (3). Considering the clinical implications of this small yet provocative study, clarifying some methodological issues would be of major practical value.
Reply
We thank Dr. Alfonso and colleagues for their concern and suggestions based on our recent publication (1) . We appreciate their suggestions and have performed the following analysis.
Focal restenosis occurs frequently at stent edges after drugeluting stent (DES) implantation (2) . In the paclitaxel-eluting balloon (PEB) group of our study, stent edge restenosis affected 3 of the 13 focal restenotic lesions. No recurrent restenosis occurred in this group. We cannot conclude that PEB was effective for stent edge restenosis, because of the small sample size in this study. We believe stent edge restenosis should be handled carefully to not cause coronary dissection.
Stent underexpansion is considered the cause of recurrent restenosis (3). We did not have adequate intravascular ultrasound data that could assess DES restenosis at the time of PEB use. In our study, pre-dilation was performed with a noncompliant balloon in all lesions. Pre-dilation pressure was higher in the conventional balloon angioplasty group than in the PEB group (21.4 Ϯ 3.7 atm vs. 19.2 Ϯ 6.4 atm; p ϭ 0.001). Balloon artery ratio was similar (1.08 Ϯ 0.07 vs. 1.10 Ϯ 0.08; p ϭ 0.3) between the groups. In the PEB group, inflation pressure for the SeQuent Please balloon catheter (B. Braun Melsungen AG, Vascular Systems, Berlin, Germany) was 13.0 Ϯ 2.4 atm. We believe that obtaining a high acute gain and avoiding stent underexpansion by
